Zevra Therapeutics (ZVRA) Price to Sales (2019 - 2026)
Zevra Therapeutics' (ZVRA) Price to Sales came in at 6.25 for Q2 2026, down 20.1% from 7.83 a year earlier but up 38.8% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Price to Sales (2019 - 2026) Analysis & Trends
For FY2025, Zevra Therapeutics' Price to Sales stood at 4.78, down 74.8% from FY2024.
- In prior years, Zevra Therapeutics' Price to Sales was 18.96 in FY2024 (+91.4%), 9.91 in FY2023 (-36.5%), 15.60 in FY2022 (-26.7%) and 21.28 in FY2021 (+178.3%).
- Quarterly Price to Sales has run from a low of 4.50 in Q1 2026 to a high of 40.16 in Q3 2022 over five years.
- On a year-over-year basis, Price to Sales has declined in each of the last five quarters, with an average decline of 8.5% over the last eight quarters.
- The strongest year-over-year quarter for Price to Sales in the past five years was Q3 2021, with growth of 247.9%; the weakest was Q4 2025, with a decline of 74.8%.
- According to Business Quant data, Price to Sales for the three prior quarters was 4.50 (Q1 2026), 4.78 (Q4 2025) and 6.33 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Zevra Therapeutics | 592.83 Mn | -219.88 Mn | 38.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.25 |
| Mar 31, 2026 | 4.50 |
| Dec 31, 2025 | 4.78 |
| Sep 30, 2025 | 6.33 |
| Jun 30, 2025 | 7.83 |
| Mar 31, 2025 | 10.10 |
| Dec 31, 2024 | 18.98 |
| Sep 30, 2024 | 15.08 |
| Jun 30, 2024 | 8.69 |
| Mar 31, 2024 | 8.76 |
| Dec 31, 2023 | 9.91 |
| Sep 30, 2023 | 10.54 |
| Jun 30, 2023 | 10.46 |
| Mar 31, 2023 | 19.88 |
| Dec 31, 2022 | 15.60 |
| Sep 30, 2022 | 40.16 |
| Jun 30, 2022 | 31.35 |
| Mar 31, 2022 | 16.89 |
| Dec 31, 2021 | 21.28 |
| Sep 30, 2021 | 23.18 |
API Access
Zevra Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();